Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study.
Identifieur interne : 001E70 ( PubMed/Checkpoint ); précédent : 001E69; suivant : 001E71Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study.
Auteurs : Kathryn H. Schmitz [États-Unis] ; Rebecca M. Speck ; Sheree A. Rye ; Tracey Disipio ; Sandra C. HayesSource :
- Cancer [ 1097-0142 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Association thérapeutique (), Association thérapeutique (effets indésirables), Australie (épidémiologie), Causalité, Comorbidité, Douleur (rééducation et réadaptation), Douleur (épidémiologie), Douleur (étiologie), Enquêtes et questionnaires, Fatigue (rééducation et réadaptation), Fatigue (épidémiologie), Fatigue (étiologie), Femelle, Humains, Indice de gravité médicale, Lymphoedème (rééducation et réadaptation), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Prise de poids, Prévalence, Qualité de vie, Répartition par âge, Soins de longue durée, Sujet âgé, Survivants, Tumeurs du sein (), Tumeurs du sein (épidémiologie), Études longitudinales.
- MESH :
- effets indésirables : Association thérapeutique.
- rééducation et réadaptation : Douleur, Fatigue, Lymphoedème.
- épidémiologie : Australie, Douleur, Fatigue, Lymphoedème, Tumeurs du sein.
- étiologie : Douleur, Fatigue, Lymphoedème.
- Adulte, Adulte d'âge moyen, Association thérapeutique, Causalité, Comorbidité, Enquêtes et questionnaires, Femelle, Humains, Indice de gravité médicale, Prise de poids, Prévalence, Qualité de vie, Répartition par âge, Soins de longue durée, Sujet âgé, Survivants, Tumeurs du sein, Études longitudinales.
- Wicri :
- geographic : Australie.
English descriptors
- KwdEn :
- Adult, Age Distribution, Aged, Australia (epidemiology), Breast Neoplasms (epidemiology), Breast Neoplasms (therapy), Causality, Combined Modality Therapy (adverse effects), Combined Modality Therapy (methods), Comorbidity, Fatigue (epidemiology), Fatigue (etiology), Fatigue (rehabilitation), Female, Humans, Long-Term Care, Longitudinal Studies, Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (rehabilitation), Middle Aged, Pain (epidemiology), Pain (etiology), Pain (rehabilitation), Prevalence, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Survivors, Weight Gain.
- MESH :
- geographic , epidemiology : Australia.
- adverse effects : Combined Modality Therapy.
- epidemiology : Breast Neoplasms, Fatigue, Lymphedema, Pain.
- etiology : Fatigue, Lymphedema, Pain.
- methods : Combined Modality Therapy.
- rehabilitation : Fatigue, Lymphedema, Pain.
- therapy : Breast Neoplasms.
- Adult, Age Distribution, Aged, Causality, Comorbidity, Female, Humans, Long-Term Care, Longitudinal Studies, Middle Aged, Prevalence, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Survivors, Weight Gain.
Abstract
There is a need to better describe and understand the prevalence of breast cancer treatment-related adverse effects amenable to physical therapy and rehabilitative exercise. Prior studies have been limited to single issues and lacked long-term follow-up. The Pulling Through Study provides data on prevalence of adverse effects in breast cancer survivors followed over 6 years.
DOI: 10.1002/cncr.27474
PubMed: 22488696
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22488696Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study.</title><author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, Pennsylvania 19104-6021, USA. schmitz@mail.med.upenn.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, Pennsylvania 19104-6021</wicri:regionArea><wicri:noRegion>Pennsylvania 19104-6021</wicri:noRegion></affiliation></author><author><name sortKey="Speck, Rebecca M" sort="Speck, Rebecca M" uniqKey="Speck R" first="Rebecca M" last="Speck">Rebecca M. Speck</name></author><author><name sortKey="Rye, Sheree A" sort="Rye, Sheree A" uniqKey="Rye S" first="Sheree A" last="Rye">Sheree A. Rye</name></author><author><name sortKey="Disipio, Tracey" sort="Disipio, Tracey" uniqKey="Disipio T" first="Tracey" last="Disipio">Tracey Disipio</name></author><author><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22488696</idno><idno type="pmid">22488696</idno><idno type="doi">10.1002/cncr.27474</idno><idno type="wicri:Area/PubMed/Corpus">002173</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002173</idno><idno type="wicri:Area/PubMed/Curation">002173</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002173</idno><idno type="wicri:Area/PubMed/Checkpoint">002173</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002173</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study.</title><author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, Pennsylvania 19104-6021, USA. schmitz@mail.med.upenn.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, Pennsylvania 19104-6021</wicri:regionArea><wicri:noRegion>Pennsylvania 19104-6021</wicri:noRegion></affiliation></author><author><name sortKey="Speck, Rebecca M" sort="Speck, Rebecca M" uniqKey="Speck R" first="Rebecca M" last="Speck">Rebecca M. Speck</name></author><author><name sortKey="Rye, Sheree A" sort="Rye, Sheree A" uniqKey="Rye S" first="Sheree A" last="Rye">Sheree A. Rye</name></author><author><name sortKey="Disipio, Tracey" sort="Disipio, Tracey" uniqKey="Disipio T" first="Tracey" last="Disipio">Tracey Disipio</name></author><author><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name></author></analytic><series><title level="j">Cancer</title><idno type="eISSN">1097-0142</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Australia (epidemiology)</term><term>Breast Neoplasms (epidemiology)</term><term>Breast Neoplasms (therapy)</term><term>Causality</term><term>Combined Modality Therapy (adverse effects)</term><term>Combined Modality Therapy (methods)</term><term>Comorbidity</term><term>Fatigue (epidemiology)</term><term>Fatigue (etiology)</term><term>Fatigue (rehabilitation)</term><term>Female</term><term>Humans</term><term>Long-Term Care</term><term>Longitudinal Studies</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Lymphedema (rehabilitation)</term><term>Middle Aged</term><term>Pain (epidemiology)</term><term>Pain (etiology)</term><term>Pain (rehabilitation)</term><term>Prevalence</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Surveys and Questionnaires</term><term>Survivors</term><term>Weight Gain</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association thérapeutique ()</term><term>Association thérapeutique (effets indésirables)</term><term>Australie (épidémiologie)</term><term>Causalité</term><term>Comorbidité</term><term>Douleur (rééducation et réadaptation)</term><term>Douleur (épidémiologie)</term><term>Douleur (étiologie)</term><term>Enquêtes et questionnaires</term><term>Fatigue (rééducation et réadaptation)</term><term>Fatigue (épidémiologie)</term><term>Fatigue (étiologie)</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Lymphoedème (rééducation et réadaptation)</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Prise de poids</term><term>Prévalence</term><term>Qualité de vie</term><term>Répartition par âge</term><term>Soins de longue durée</term><term>Sujet âgé</term><term>Survivants</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (épidémiologie)</term><term>Études longitudinales</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Australia</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Combined Modality Therapy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Association thérapeutique</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Fatigue</term><term>Lymphedema</term><term>Pain</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Fatigue</term><term>Lymphedema</term><term>Pain</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Combined Modality Therapy</term></keywords><keywords scheme="MESH" qualifier="rehabilitation" xml:lang="en"><term>Fatigue</term><term>Lymphedema</term><term>Pain</term></keywords><keywords scheme="MESH" qualifier="rééducation et réadaptation" xml:lang="fr"><term>Douleur</term><term>Fatigue</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Australie</term><term>Douleur</term><term>Fatigue</term><term>Lymphoedème</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Douleur</term><term>Fatigue</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Causality</term><term>Comorbidity</term><term>Female</term><term>Humans</term><term>Long-Term Care</term><term>Longitudinal Studies</term><term>Middle Aged</term><term>Prevalence</term><term>Quality of Life</term><term>Severity of Illness Index</term><term>Surveys and Questionnaires</term><term>Survivors</term><term>Weight Gain</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Association thérapeutique</term><term>Causalité</term><term>Comorbidité</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Prise de poids</term><term>Prévalence</term><term>Qualité de vie</term><term>Répartition par âge</term><term>Soins de longue durée</term><term>Sujet âgé</term><term>Survivants</term><term>Tumeurs du sein</term><term>Études longitudinales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is a need to better describe and understand the prevalence of breast cancer treatment-related adverse effects amenable to physical therapy and rehabilitative exercise. Prior studies have been limited to single issues and lacked long-term follow-up. The Pulling Through Study provides data on prevalence of adverse effects in breast cancer survivors followed over 6 years.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22488696</PMID><DateCreated><Year>2012</Year><Month>04</Month><Day>10</Day></DateCreated><DateCompleted><Year>2012</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-0142</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>8 Suppl</Issue><PubDate><Year>2012</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Cancer</Title><ISOAbbreviation>Cancer</ISOAbbreviation></Journal><ArticleTitle>Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study.</ArticleTitle><Pagination><MedlinePgn>2217-25</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.27474</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is a need to better describe and understand the prevalence of breast cancer treatment-related adverse effects amenable to physical therapy and rehabilitative exercise. Prior studies have been limited to single issues and lacked long-term follow-up. The Pulling Through Study provides data on prevalence of adverse effects in breast cancer survivors followed over 6 years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A population-based sample of Australian women (n = 287) diagnosed with invasive, unilateral breast cancer was followed for a median of 6.6 years and prospectively assessed for treatment-related complications at 6, 12, and 18 months and 6 years after diagnosis. Assessments included postsurgical complications, skin or tissue reaction to radiation therapy, upper-body symptoms, lymphedema, 10% weight gain, fatigue, and upper-quadrant function. The proportion of women with positive indication for each complication and 1 or more complication was estimated using all available data at each time point. Women were only considered to have a specific complication if they reported the highest 2 levels of the Likert scale for self-reported issues.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At 6 years after diagnosis, more than 60% of women experienced 1 or more side effects amenable to rehabilitative intervention. The proportion of women experiencing 3 or more side effects decreased throughout follow-up, whereas the proportion experiencing no side effects remained stable around 40% from 12 months to 6 years. Weight gain was the only complication to increase in prevalence over time.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data support the development of a multidisciplinary prospective surveillance approach for the purposes of managing and treating adverse effects in breast cancer survivors.</AbstractText><CopyrightInformation>Copyright © 2012 American Cancer Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmitz</LastName><ForeName>Kathryn H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Division of Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Abramson Cancer Center, Philadelphia, Pennsylvania 19104-6021, USA. schmitz@mail.med.upenn.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speck</LastName><ForeName>Rebecca M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Rye</LastName><ForeName>Sheree A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>DiSipio</LastName><ForeName>Tracey</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Sandra C</ForeName><Initials>SC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer</MedlineTA><NlmUniqueID>0374236</NlmUniqueID><ISSNLinking>0008-543X</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015430" MajorTopicYN="N">Weight Gain</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22488696</ArticleId><ArticleId IdType="doi">10.1002/cncr.27474</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Disipio, Tracey" sort="Disipio, Tracey" uniqKey="Disipio T" first="Tracey" last="Disipio">Tracey Disipio</name><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C" last="Hayes">Sandra C. Hayes</name><name sortKey="Rye, Sheree A" sort="Rye, Sheree A" uniqKey="Rye S" first="Sheree A" last="Rye">Sheree A. Rye</name><name sortKey="Speck, Rebecca M" sort="Speck, Rebecca M" uniqKey="Speck R" first="Rebecca M" last="Speck">Rebecca M. Speck</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001E70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:22488696
|texte= Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the Pulling Through Study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22488696" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |